title: American Gastroenterological Association institute medical position statement on the use of gastrointestinal medication in pregnancy.
authors.forename: Arthur
authors.initials: A
authors.lastname: Staroselsky
authors.forename: Facundo
authors.initials: F
authors.lastname: Garcia-Bournissen
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use; D004025:Dicyclomine; D004319:Doxylamine / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D048968:Morning Sickness / Q000188:drug therapy; D009325:Nausea / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States; D014839:Vomiting / Q000188:drug therapy
chemical_list: D000932:Antiemetics; D004338:Drug Combinations; D005765:Gastrointestinal Agents; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine